In a study performed in Copenhagen, Vioxx and Celebrex were found to increase the chances of death to a patient who had survived a heart attack. The findings were released at an American Heart Association on Sunday.
Dr. Gunnar Gislason of the Bispebjerg University Hospital stated that patients taking 25 milligrams of rofecoxib, the content of Vioxx, is five times more likely to fall to heart disease than those who do not take the drug.
Similar findings were observed with another known painkiller: Celebrex.
